Boston Scientific Consolidation Aimed At Saving $250 Mil. Annually By 2003
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific's decision to close three of its manufacturing facilities over the next 18 months combined with the elimination of 1,000 positions is expected to contribute to annual cost savings of $250 mil. by 2003.
You may also be interested in...
J&J Puts U.S. Coronary Stent Market Share At 15-18% Exiting Second Quarter
Johnson & Johnson estimates its share of the U.S. coronary stent market at 15-18% exiting the second quarter on the strength of its BX Velocity stent.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.